rac-nor laudanosine
CAS: 13074-31-2
Ref. 3D-FR27650
| 1kg | To inquire | ||
| 2kg | To inquire | ||
| 5kg | To inquire | ||
| 10kg | To inquire | ||
| 500g | To inquire |
Product Information
- 1-[(3,4-Dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinoline1,2,3,4-Tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline (±)-N-Norlaudanosine
- (+/-)-Tetrahydropapaverine
- (±)-N-Norlaudanosine
- (±)-Norlaudanosine
- 1,2,3,4-Tetrahydropapaverine
- 1-(3,4-Dimethoxybenzyl)-6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline
- 1-(3,4-Dimethoxybenzyl)-6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinolinium Chloride
- 1-[(3,4-Dimethoxyphenyl)Methyl]-1,2,3,4-Tetrahydro-6,7-Dimethoxyisoquinoline
- Isoquinoline, 1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratryl-
- Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-
- See more synonyms
Rac-nor laudanosine is a potent dopamine receptor agonist that is used for the treatment of Parkinson's disease. It has been shown to inhibit cell growth in culture and reduce acid formation, which may be due to its ability to inhibit cyclic nucleotide phosphodiesterases. Rac-nor laudanosine also inhibits the production of dopamine from tyrosine by inhibiting the conversion of dopamine into dihydroxyphenylalanine via the enzyme tyrosine hydroxylase. The asymmetric synthesis of rac-nor laudanosine allows it to have a high yield with less reaction time and fewer steps. This drug was shown to bind in vitro to human receptors.
Chemical properties
Technical inquiry about: 3D-FR27650 rac-nor laudanosine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
